AL

Andrew Luster

The General Hospital: 7 patents #232 of 3,021Top 8%
Harvard University: 6 patents #309 of 3,600Top 9%
BH Brigham and Women's Hospital: 2 patents #490 of 1,764Top 30%
MIT: 1 patents #4,386 of 9,367Top 50%
📍 Wellesley, MA: #136 of 837 inventorsTop 20%
🗺 Massachusetts: #10,511 of 88,656 inventorsTop 15%
Overall (All Time): #410,711 of 4,157,543Top 10%
12
Patents All Time

Issued Patents All Time

Showing 1–12 of 12 patents

Patent #TitleCo-InventorsDate
11485781 Multiple specificity binders of CXC chemokines Alessandro Angelini, Karl Dane Wittrup 2022-11-01
7775469 Purposeful movement of human migratory cells away from an agent source Mark C. Poznansky, David T. Scadden 2010-08-17
7141363 Purposeful movement of human migratory cells away from an agent source Mark C. Poznansky, David T. Scadden 2006-11-28
6949637 Methods for diagnosis, prediction and treatment of asthma and other inflammatory conditions based on eotaxin coding sequence polymorphism Craig M. Lilly, Jeffrey M. Drazen 2005-09-27
6780973 Eotaxin: an eosinophil chemoattractant Philip Leder, Marc Rothenberg, Eduardo Alejandro Garcia 2004-08-24
6673915 Nucleic acid encoding monocyte chemotactic protein 4 Eduardo A. Garcia-Zepeda, Mindy N. Sarafi 2004-01-06
6548245 Methods for diagnosis, prediction and treatment of asthma and other inflammatory conditions based on eotaxin coding sequence polymorphism Craig M. Lilly, Jeffrey M. Drazen 2003-04-15
6403782 Nucleic acid encoding eotaxin Philip Leder, Marc Rothenberg, Eduardo Alejandro Garcia 2002-06-11
6153600 Use of the cytokine IP-10 as an anti-tumor agent Philip Leder 2000-11-28
5935567 Cytokine IP-10 as an anti-tumor agent Philip Leder 1999-08-10
5824299 Modulation of endothelial cell proliferation with IP-10 Philip Leder 1998-10-20
5474981 Use of the cytokine IP-10 as an anti-tumor agent Philip Leder 1995-12-12